🇺🇸 FDA
Patent

US 9422271

Pyrimidine compounds as tuberculosis inhibitors

granted A61KA61K31/506A61K31/519

Quick answer

US patent 9422271 (Pyrimidine compounds as tuberculosis inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/506, A61K31/519, A61K31/5377, A61K31/551